Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Li, X.-Z.
Right arrow Articles by Poole, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X.-Z.
Right arrow Articles by Poole, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 45, 433-436
© 2000 The British Society for Antimicrobial Chemotherapy

Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa

Xian-Zhi Li, Li Zhang and Keith Poole*

Department of Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada K7L 3N6

MexAB-OprM is a constitutively expressed multidrug efflux system of Pseudomonas aeruginosa. Using isogenic pump mutants, the contributions of the MexAB-OprM efflux pump and the outer membrane barrier to multiple antibiotic resistance were evaluated by assessing the influence of pump inactivation and outer membrane permeabilization on antibiotic susceptibility. Both pump inactivation and increased outer membrane permeability enhanced antibiotic susceptibility, although maximal susceptibility was achieved when the two were combined. Thus, inhibition of antibiotic efflux pumps and permeabilization of the outer membrane constitute an effective approach to reversing the antibiotic resistance of this organism.

* Corresponding author. Tel: +1-613-533-6677; Fax: +1-613-533-6796; E-mail: poolek{at}post.queensu.ca


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Med MicrobiolHome page
W.-H. Zhao, G. Chen, R. Ito, and Z.-Q. Hu
Relevance of resistance levels to carbapenems and integron-borne blaIMP-1, blaIMP-7, blaIMP-10 and blaVIM-2 in clinical isolates of Pseudomonas aeruginosa
J. Med. Microbiol., August 1, 2009; 58(8): 1080 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. Vettoretti, P. Plesiat, C. Muller, F. El Garch, G. Phan, I. Attree, A. Ducruix, and C. Llanes
Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1987 - 1997.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
W.-H. Zhao, Z.-Q. Hu, and T. Shimamura
Potency of IMP-10 metallo-{beta}-lactamase in hydrolysing various antipseudomonal {beta}-lactams
J. Med. Microbiol., August 1, 2008; 57(8): 974 - 979.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
L. Pumbwe, O. Ueda, F. Yoshimura, A. Chang, R. L. Smith, and H. M. Wexler
Bacteroides fragilis BmeABC efflux systems additively confer intrinsic antimicrobial resistance
J. Antimicrob. Chemother., July 1, 2006; 58(1): 37 - 46.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. H. Kwon and C.-D. Lu
Polyamines Increase Antibiotic Susceptibility in Pseudomonas aeruginosa.
Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1623 - 1627.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
L. Drago, E. De Vecchi, L. Nicola, L. Tocalli, and M. R. Gismondo
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with {beta}-lactams and amikacin
J. Antimicrob. Chemother., August 1, 2005; 56(2): 353 - 359.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. L. Sobel, D. Hocquet, L. Cao, P. Plesiat, and K. Poole
Mutations in PA3574 (nalD) Lead to Increased MexAB-OprM Expression and Multidrug Resistance in Laboratory and Clinical Isolates of Pseudomonas aeruginosa
Antimicrob. Agents Chemother., May 1, 2005; 49(5): 1782 - 1786.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
D. Nehme, X.-Z. Li, R. Elliot, and K. Poole
Assembly of the MexAB-OprM Multidrug Efflux System of Pseudomonas aeruginosa: Identification and Characterization of Mutations in mexA Compromising MexA Multimerization and Interaction with MexB
J. Bacteriol., May 15, 2004; 186(10): 2973 - 2983.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. R. Dean, M. A. Visalli, S. J. Projan, P.-E. Sum, and P. A. Bradford
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Antimicrob. Agents Chemother., March 1, 2003; 47(3): 972 - 978.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Okamoto, N. Gotoh, and T. Nishino
Extrusion of Penem Antibiotics by Multicomponent Efflux Systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa
Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2696 - 2699.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Okamoto, N. Gotoh, and T. Nishino
Pseudomonas aeruginosa Reveals High Intrinsic Resistance to Penem Antibiotics: Penem Resistance Mechanisms and Their Interplay
Antimicrob. Agents Chemother., July 1, 2001; 45(7): 1964 - 1971.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
W. Mao, M. S. Warren, A. Lee, A. Mistry, and O. Lomovskaya
MexXY-OprM Efflux Pump Is Required for Antagonism of Aminoglycosides by Divalent Cations in Pseudomonas aeruginosa
Antimicrob. Agents Chemother., July 1, 2001; 45(7): 2001 - 2007.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
D. M. Livermore
Of Pseudomonas, porins, pumps and carbapenems
J. Antimicrob. Chemother., March 1, 2001; 47(3): 247 - 250.
[Full Text] [PDF]


Home page
J. Bacteriol.Home page
K. Evans, L. Adewoye, and K. Poole
MexR Repressor of the mexAB-oprM Multidrug Efflux Operon of Pseudomonas aeruginosa: Identification of MexR Binding Sites in the mexA-mexR Intergenic Region
J. Bacteriol., February 1, 2001; 183(3): 807 - 812.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
O. Lomovskaya, M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, et al.
Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy
Antimicrob. Agents Chemother., January 1, 2001; 45(1): 105 - 116.
[Abstract] [Full Text]


Home page
J Antimicrob ChemotherHome page
X.-Z. Li, N. Barre, and K. Poole
Influence of the MexA-MexB-OprM multidrug efflux system on expression of the MexC-MexD-OprJ and MexE-MexF-OprN multidrug efflux systems in Pseudomonas aeruginosa
J. Antimicrob. Chemother., December 1, 2000; 46(6): 885 - 893.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Poole
Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria
Antimicrob. Agents Chemother., September 1, 2000; 44(9): 2233 - 2241.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.